Elizabeth Phillips

November 19, 2024

Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

By Bill Snyder
(iStock)
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.

By Paul Govern
Cosby Stone Jr., MD, MPH, examines patient Gregory Barker’s arm following Barker’s allergy test. (photo by Erin O. Smith)
September 18, 2024

Clinic marks 10th year of diagnosis and treatment of drug allergies

The clinic, celebrating its 10th year, has seen groundbreaking discoveries in personalized care and diagnosis for allergy, especially delayed drug allergy, and has advanced discoveries in the optimal process to test patients for drug allergies.

By Nancy Humphrey
Mark Denison, MD, and Xiaotao Lu, MS, are among those on a new list of scientists whose papers have been cited the most frequently by other researchers. (photo by Erin O. Smith)
November 15, 2023

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.

By Bill Snyder
April 27, 2023

Phillips elected to Association of American Physicians

Vanderbilt’s Elizabeth Phillips, MD, has been elected to membership in the Association of American Physicians

By Bill Snyder
September 29, 2022

Penicillin delabeling initiative expanding to more patient care areas

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.

By Paul Govern
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
By Jessica Pasley
August 12, 2021

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.
By Paul Govern
July 27, 2021

Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.
By Nancy Humphrey
October 1, 2020

Genes spell penicillin allergy risk

Studies using large DNA biobanks revealed genetic variants associated with penicillin allergy, the most common type of drug-induced allergic reaction.
By Paul Govern
May 6, 2020

New rule outlines when to challenge a penicillin allergy

According to the U.S. Centers for Disease Control and Prevention, fewer than 1% of the population is truly allergic to penicillin. The rest were never allergic to begin with or have outgrown their allergy — an estimated 80% of people with penicillin allergy lose their sensitivity to the drug within 10 years.
By Paul Govern
October 17, 2019

Effort to remove penicillin allergy labels seeing success

A program in the Medical Intensive Care Unit has successfully removed penicillin allergy labels from more than 45 inpatients at high risk to receive antibiotics, but whose penicillin allergies were low risk.
By Nancy Humphrey
February 28, 2019

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.
By Bill Snyder
1 2